Monday, 5 August, 2024
Neuralink Successfully Implants Brain Chip In Second Trial Patient
Neuralink, Elon Musk's brain-computer interface company, has successfully implanted its brain chip in a second trial patient. This milestone marks significant progress in Neuralink's clinical trials aimed at treating neurological conditions. The implant is designed to facilitate direct communication between the brain and external devices, potentially revolutionizing medical treatments and enhancing human cognitive abilities through advanced neurotechnology.
Read full story at Economic Times